<DOC>
	<DOCNO>NCT02893085</DOCNO>
	<brief_summary>The differential diagnosis benign malignant bile duct strictures difficult demand task clinician . Clinical , biochemical , radiological characteristic malignant biliary stricture non-specific tissue diagnosis difficult obtain preoperatively . For reason , need development new diagnostic modality . Of particular interest quest tumor marker secrete shed bile tumor cell develop biliary tract . In addition , patient 's tumor molecular profile basis select personalize therapy . Cholangiocarcinomas characterize large genetic heterogeneity . The frequent mutation TP53 , KRAS , BRAF , EGFR , MET , NRAS , PIK3CA , ERBB2 , SMAD4 , FBXW7 , ARID1A , PBRM1 , BAP1 et IDH1/2 . In case pancreatic cancer , frequent KRAS mutation detect 90 % patient CDKN2A , SMAD4 , TGFBR1 , TGFBR2 , ATM , BRCA2 , MLL2 , MLL3 , KDM6A , ARID1A , ARID1B , SMARC1 , GNAS RNF43 mutation . It well establish KRAS P53 mutation detect bile sample patient biliary stricture relate cholangiocarcinoma cancer head pancreas . The main objective determine bile sample analysis patient malignant biliary stricture may allow identify tumor mutation profile determine tumor genotype . A secondary objective evaluate diagnostic value Vascular Endothelial Growth Factor ( VEGF ) metallo-proteinases ( MMPs ) level bile sample . Tumor genotyping perform bile sample ( supernatant cell pellet ) tumor tissue series 10 patient surgically treat malignant biliary stricture relate cholangiocarcinoma cancer head pancreas . The biochemical marker , VEGF MMPs , assess bile sample obtain endoscopic retrograde cholangiopancreatography 50 patient malignant biliary stricture 50 patient treated benign biliary disease .</brief_summary>
	<brief_title>Pancreatico-biliary Tumor Mutation Profiling Bile Samples</brief_title>
	<detailed_description />
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>1 . Tumor genotyping bile sample : Inclusion criterion : patient surgically treat malignant biliary stricture relate cholangiocarcinoma cancer head pancreas . diagnosis cholangiocarcinoma cancer head pancreas confirm histopathological analysis resect specimen adult patient Exclusion criterion : patient accept storage bile tissue tissue Bank Reims university hospital 2 . Measurement biochemical marker , VEGF MMPs bile sample obtain endoscopic retrograde cholangiopancreatography 50 patient malignant biliary stricture 50 patient treated benign biliary disease . Inclusion criterion : patient benign biliary disease malignant biliary stricture ( cholangiocarcinoma cancer head pancreas . indication endoscopic retrograde cholangiopancreatography diagnostic therapeutic purpose adult patient Exclusion criterion patient accept storage bile tissue tissue Bank Reims university hospital</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>